日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Persistently high prevalence of HPV16 and rising prevalence of non-16/18 HR-HPV genotypes in cervical precancer and cancer in Latvia in 2016-2024 shape the severity of cervical disease

2016-2024年间,拉脱维亚宫颈癌前病变和宫颈癌中HPV16持续高发以及非16/18型高危HPV基因型感染率上升,影响着宫颈疾病的严重程度。

Sokolovska, Liba; Biserova, Karina; Spridzane, Arta; Krisane, Daira; Dudorova, Alesja; Gebrila, Svetlana; Krasovska, Ilvija; Perminov, Dmitry; Orlova, Beatrise; Petrovska, Marta; Jansons, Juris; Mitildzans, Androniks; Nazarovs, Jurijs; Isaguliants, Maria

New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines.

基于表达 HPV16 E6 和 E7 的腺癌 4T1 细胞的新型小鼠模型,用于评估基于 E6/E7 的治疗性和预防性 HPV16 疫苗的疗效

Jansons Juris, Avdoshina Daria, Dudorova Alesja, Rubio Elena Royo, Sokolovska Liba, Perminov Dmitry, Lindenberga Ilze, Nicolai Hannes, Gebrila Svetlana, Chowdhury Sona, Skrastina Dace, Nazarovs Jurijs, Palefsky Joel M, Isaguliants Maria